Showing results (4631-4640 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 30, 2014
Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effectsKathleen Beusterien, Jessica Grinspan, Iryna Kuchuk, et al.
The Oncologist|March 26, 2017
A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)Michio Nakamura, Atsushi Ishiguro, Tetsuhito Muranaka, et al.
The Oncologist|April 15, 2017
Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint DesignCharu Aggarwal, Hossein Borghaei
The Oncologist|April 15, 2017
National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer PatientsYu-Yun Shao, Emily Han-Chung Hsiue, Chih-Hung Hsu, et al.
The Oncologist|April 15, 2017
Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical ValuesSarah K Walsh, Elizabeth S Ginsburg, Lisa Soleymani Lehmann, et al.
The Oncologist|March 27, 2014
Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912Daisuke Takahari, Narikazu Boku, Junki Mizusawa, et al.
The Oncologist|March 27, 2014
Cervical cancer-related knowledge, attitudes, and practices of health professionals working in brazil's network of primary care unitsAnalía Romina Stormo, Lenildo de Moura, Mona Saraiya
The Oncologist|March 27, 2014
Current cervical cancer screening knowledge, awareness, and practices among U.S. affiliated pacific island providers: opportunities and challengesJulie S Townsend, Analía Romina Stormo, Katherine B Roland, et al.
The Oncologist|March 29, 2014
An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancerRocio Garcia-Carbonero, Fernando Rivera, Joan Maurel, et al.
The Oncologist|March 29, 2014
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcomaElizabeth R Plimack, Tingting Tan, Yu-Ning Wong, et al.
Pageof 571